Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Induction Healthcare Group's 3-Year RORE % for the quarter that ended in Sep. 2024 was -14.29%.
The industry rank for Induction Healthcare Group's 3-Year RORE % or its related term are showing as below:
LSE:INHC's 3-Year RORE % is ranked worse than 64.05% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: -0.2
vs LSE:INHC: -14.29
Induction Healthcare Group 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Induction Healthcare Group's 3-Year RORE %
For the Health Information Services subindustry, Induction Healthcare Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Induction Healthcare Group's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Induction Healthcare Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Induction Healthcare Group's 3-Year RORE % falls into.
Induction Healthcare Group 3-Year RORE % Calculation
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 3-year before.
Induction Healthcare Group (LSE:INHC) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Induction Healthcare Group 3-Year RORE % Related Terms
Thank you for viewing the detailed overview of Induction Healthcare Group's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Induction Healthcare Group PLC is a healthcare technology company focused on streamlining the delivery of care by Healthcare Professionals. The company's mobile application module Induction Switch is an app that provides a directory allowing Healthcare Professionals to find extension numbers, messaging, and administration portals to share and view hospital guidelines. The company's products power remote consultations, capture patient-reported data and empower patients to self-manage their care pathway. Geographically, it operates in the United Kingdom, Europe, the United States and the Rest of the world, out of which the majority of revenue is derived from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:INHC has been successfully added to your 